Global Sanger-based Diagnostics Testing Market Research Report - Segmented by Product type (Sequencing Instruments, Sequencing Consumables, Software Solutions), By End-users (Hospitals, Diagnostic Laboratories, Research Institutions, Academic Centers, Others), By Application (Disease Diagnostics, Biomarkers & Cancer Testing, Genetic Disorders, Personalized Medicines, Forensics, Reproductive Health, Others), and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15488
Format:
Region: Global
Chapter 1. Sanger-based Diagnostics Testing Market - Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Sanger-based Diagnostics Testing Market - Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2024 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Sanger-based Diagnostics Testing Market - Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. Sanger-based Diagnostics Testing Market - Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Sanger-based Diagnostics Testing Market - Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Sanger-based Diagnostics Testing Market - By Product Type
6.1 Sequencing Instruments
6.2 Sequencing Consumables
6.3 Software Solutions
Chapter 7. Sanger-based Diagnostics Testing Market - By End User
7.1 Hospitals
7.2 Diagnostic Laboratories
7.3 Research Institutions
7.4 Academic Centers
7.5 Others
Chapter 8. Sanger-based Diagnostics Testing Market - By Application
8.1 Disease Diagnostics
8.2 Biomarkers & Cancer Testing
8.3 Genetic Disorders
8.4 Personalized Medicines
8.5 Forensics
8.6 Reproductive Health
8.7 Others
Chapter 9. Sanger-based Diagnostics Testing Market – By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Latin America
9.5 The Middle East
9.6 Africa
Chapter 10. Sanger-based Diagnostics Testing Market – Key players
10.1 Thermo Fisher Scientific Inc
10.2 Source BioScience
10.3 GenScript
10.4 Quintara Biosciences
10.5 GENEWIZ
10.6 LGC Ltd
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
According to the report published by Virtue Market Research in Global Sanger-based Diagnostics Testing Market was valued at USD 5.52 Billion and is projected to reach a market size of USD 16.88 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 17.30%
Rising demand for Precision Medicine has led to rapid growth in the global Sanger-based diagnostics testing market.
Sequencing Instruments, Sequencing Consumables and Software Solutions are the segments by product type under the Global Sanger-based Diagnostics Testing Market.
North America dominates the market in Global Sanger-based Diagnostics Testing Market.
Asia-Pacific is the fastest-growing region in the Global Sanger-based Diagnostics Testing Market.
